Medigus (NASDAQ:MDGS – Get Rating) and Inari Medical (NASDAQ:NARI – Get Rating) are both business services companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, valuation, dividends, profitability, analyst recommendations, institutional ownership and risk.
This is a summary of current ratings and price targets for Medigus and Inari Medical, as reported by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
Inari Medical has a consensus target price of $89.11, suggesting a potential upside of 29.26%. Given Inari Medical’s higher possible upside, analysts plainly believe Inari Medical is more favorable than Medigus.
|Net Margins||Return on Equity||Return on Assets|
Institutional & Insider Ownership
9.2% of Medigus shares are held by institutional investors. Comparatively, 85.2% of Inari Medical shares are held by institutional investors. 2.2% of Medigus shares are held by insiders. Comparatively, 13.7% of Inari Medical shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.
Valuation & Earnings
This table compares Medigus and Inari Medical’s gross revenue, earnings per share (EPS) and valuation.
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|Medigus||$91.86 million||0.06||-$9.81 million||N/A||N/A|
|Inari Medical||$383.47 million||10.28||-$29.27 million||($0.53)||-130.08|
Medigus has higher earnings, but lower revenue than Inari Medical.
Risk & Volatility
Medigus has a beta of 0.08, meaning that its stock price is 92% less volatile than the S&P 500. Comparatively, Inari Medical has a beta of 1.12, meaning that its stock price is 12% more volatile than the S&P 500.
Inari Medical beats Medigus on 7 of the 11 factors compared between the two stocks.
Medigus Ltd., a technology-based company, provides medical-related devices and products in the United States, Europe, China, Israel, and internationally. It offers Medigus Ultrasonic Surgical Endostapler, an endoscopy system, which is used for the treatment of gastroesophageal reflux disease. The company also develops biological gels to protect patients against biological threats and reduce the intrusion of allergens and viruses through the upper airways and eye cavities. In addition, it develops, markets, and distributes software for internet users; and operates online stores for the sale of various consumer products on the Amazon online marketplace, as well as an online event management and ticketing platform. Further, the company develops, produces, and markets miniaturized imaging equipment, visualization solutions, and resistant cameras; electric vehicles; and wireless vehicle battery charging technologies. Medigus Ltd. was incorporated in 1999 and is headquartered in Tel Aviv-Yafo, Israel.
About Inari Medical
Inari Medical, Inc., a medical device company, develops, manufactures, markets, and sells devices for the interventional treatment of venous diseases in the United States. The company provides ClotTriever, a mechanical thrombectomy system, which is designed to core, capture, and remove large clots from large vessels, as well as for treatment of deep vein thrombosis; and FlowTriever, a large bore catheter-based aspiration and mechanical thrombectomy system, for treatment of pulmonary embolism. It also offers FlowSaver; FlowStasis, a large bore suture retention device designed to address various aspects of venous access site; and FlowTriever 2, a new disk shape designed to capture and remove wall adherent clot and shorten treatment. The company was formerly known as Inceptus Newco1 Inc. and changed its name to Inari Medical, Inc. in September 2013. Inari Medical, Inc. was incorporated in 2011 and is headquartered in Irvine, California.
Receive News & Ratings for Medigus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medigus and related companies with MarketBeat.com's FREE daily email newsletter.